OGEN vs REG · rev $37.7K vs P/E 34, $12.93B cap
Oragenics Inc (OGEN) versus Regency Centers Corporation (REG) — a side-by-side from cached financials, not a winner call.
Oragenics Inc (OGEN) is a biotechnology company listed on US.
Regency Centers Corporation (REG) is a reit - retail company listed on US.
Latest reported OGEN revenue for 2023-12-31 was $37.7K. Net income was -$20.7M. Revenue was down 71.4% from 2022-12-31 to 2023-12-31. OGEN currently screens at market cap $2.7M.
REG does not have a complete income-statement cache yet.
OGEN currently screens at market cap $2.7M. REG currently screens at market cap $12.93B and trailing P/E 33.5.
Not investment advice. Open the OGEN and REG stock pages for the full models.
Not investment advice.